Johnson & Johnson Covid vaccine suspended by FDA and CDC after 6 out of almost 7 million had blood clots and one died
STATES across the US are halting the use of the Johnson & Johnson single-dose Covid vaccine following a recommendation by the FDA and CDC over blood clot concerns.
Federal health agencies have called for use of the vaccine to be paused immediately today so that rare cases of blood clots can be investigated "out of an abundance of caution".
Just a few weeks later, however, on April 1, Cosme tested positive for Covid and later became hospitalized after his condition worsened.
He remains in a critical condition at John F. Kennedy Medical Center, where he is also being treated for pneumonia.
It comes after Europe’s drug regulator the European Medicines Agency (EMA) launched a safety review into the jab after one person died from a blood clot after receiving the vaccine.
The Janssen jab is currently not in use in the UK, but could be by the summer.
At the end of February, the Food & Drug Administration granted emergency approval for Johnson & Johnson's Covid vaccine in the US.
It was considered a game-changer at the time since it only required one shot.
READ MORE SUN STORIES
The other two approved vaccines -- from Pfizer and Moderna -- both require a booster.
The J&J approval has been instrumental in the country's ramped up efforts to get all American adults who want the vaccine access to it.